Review of RM-1929 Near-Infrared Photoimmunotherapy Clinical Efficacy for Unresectable and/or Recurrent Head and Neck Squamous Cell Carcinoma

Review of RM-1929 Near-Infrared Photoimmunotherapy Clinical Efficacy for Unresectable and/or Recurrent Head and Neck Squamous Cell Carcinoma

Head and neck squamous cell carcinoma (HNSCC) contribute to a significant global cancer burden. Developments in current therapeutic approaches have improved patient outcomes but have limited efficacy in patients with unresectable and/or recurrent HNSCC. RM-1929 near-infrared photoimmunotherapy (NIR-...

Full description

Bibliographic Details
Main Authors: Nanami L. Miyazaki, Aki Furusawa, Peter L. Choyke, Hisataka Kobayashi
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Cancers
Subjects:
RM-1929
photoimmunotherapy
cetuximab-IR700
cetuximab sarotalocan sodium
recurrent head and neck squamous cell carcinoma (HNSCC)
Online Access:https://www.mdpi.com/2072-6694/15/21/5117

Internet

https://www.mdpi.com/2072-6694/15/21/5117

Similar Items